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Abstract 
As maladaptive disgust responses are linked to mental health problems, and cancer patients 
may experience heightened disgust as a result of treatments they receive, we explored the 
associations between disgust-related side-effects and symptoms of depression and anxiety in 
people treated for cancer.  One hundred and thirty two (83 women, Mage = 57.48 years) 
participants answered questions about their treatments, side-effects, disgust responding, and 
mental health.  Experiencing bowel and/or bladder problems, sickness and/or nausea (referred 
to here as “core” disgust-related side-effects) was significantly related to greater symptoms of 
depression and borderline increased anxiety.  Further, these links were explained by a 
moderated mediation model, whereby the effects of core disgust side-effects on depression 
and anxiety were mediated by (physical and behavioural) self-directed disgust, and disgust 
propensity moderated the effect of core disgust side-effects on self-disgust.  These findings 
stress the importance of emotional responses, like disgust, in psychological adaptation to the 
side-effects of cancer treatments. 
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Introduction 
 Cancer is a major public health problem and the leading cause of death in England 
and Wales (Office for National Statistics, 2015).  The mental health of cancer patients has 
significant effects on their overall quality of life (e.g., Skarstein, Aass, Fosså, Skovlund, & 
Dahl, 2000), responses to treatment (e.g., DiMatteo, Lepper, & Croghan, 2000), and survival 
times (e.g., Falagas et al., 2007).  While estimates vary, of the most common mental health 
problems, the prevalence of depression and anxiety in people with cancer has been 
conservatively estimated to be around twice that of the general population (Hinz et al., 2010; 
Walker et al., 2014).  Common mental health problems, such as depression and anxiety, can 
be experienced as a consequence of cancer treatment regimens (e.g., Spiegel, 1997), as well 
as affecting how well cancer patients respond to them (DiMatteo et al., 2000).     
 Depression and anxiety in cancer patients are associated with decreased treatment 
adherence (e.g., Arrieta et al., 2013), greater healthcare costs and longer hospital stays (e.g., 
Hosaka, Aoki, Watanabe, Okuyama, & Kurosawa, 1999), lower chances of survival (e.g., 
Falagas et al., 2007), and an increased risk of suicide (e.g., Llorente et al., 2005).  Given these 
and other significant consequences of common mental health problems in people with cancer 
(which may go unrecognised and untreated; Walker et al., 2014), being able to identify which 
patients may be particularly vulnerable to developing symptoms of depression and anxiety, 
and which factors may be important in their antecedence, is increasingly important, as is 
recognising psychological factors to target during psycho-therapeutic interventions.  
  Increasingly, one’s emotional reactions are being understood as important, yet 
historically underexplored, predictors of mental health outcomes (Whelton & Greenberg, 
2005).  Experiencing cancer, and cancer treatment, can elicit multiple negative emotional 
responses (e.g., Kennifer et al., 2009).  One prominent, yet under-researched, emotion 
relevant to the experience of cancer is disgust.  Individuals with cancer potentially have to 
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confront a range of disgust-inducing stimuli, including, but not being limited to, becoming a 
“diseased” or “contaminating” object (Neal et al., 2007), sickness and nausea (e.g., Carey & 
Burish, 1988), bowel and bladder problems (e.g., Bauer, Bastian, Gozzi, & Stief, 2009), 
changes to an idealised body envelope (e.g., Bredin, 1999), and the salience of their own 
mortality and death (e.g., Goldenberg, Arndt, Hart, & Routledge, 2008).  Moreover, the 
majority of these may not be caused by the cancer itself, but as side-effects of the treatments 
patients receive.  A study in people with a colostomy, for example, demonstrated significant 
negative relationships between a bowel-related disgust measure and individuals’ adjustment 
to colostomy and their overall life satisfaction (Smith, Loewenstein, Rozin, Sherriff, & Ubel, 
2007).  Further experimental work has shown that trait and state disgust indices may interact 
in deterring help-seeking behaviour for bowel-related symptoms (Reynolds, McCambridge, 
Bissett, & Consedine, 2014).       
 Maladaptive disgust responding (e.g., experiencing heightened levels of disgust) has 
been linked to mental health problems, including anxiety (Cisler, Olatunji, & Lohr, 2009) and 
depression (Alanazi, Powell, & Power, 2015), by a considerable literature (Davey, 2011).  
Thus, one potential yet underexplored link between the experience of cancer and depressive 
and/or anxious outcomes is individuals’ maladaptive disgust responses, which may be 
associated with certain side-effects that are typical of cancer treatments (e.g., problems with 
body waste products, including incontinence, diarrhoea, and vomiting as a result of 
chemotherapy, or physical deformities as a consequence of surgery).    
 Disgust is a universal human emotion (Ekman, 1999), whose primary function is to 
protect us from the risk of disease (Curtis, Aunger, & Rabie, 2004).  Through evolutionary 
exaptation, disgust has expanded from an oral inhibition response (which has adaptive value 
in protecting an organism from ingesting harmful substances; Rozin & Fallon, 1987), to an 
emotion that facilitates the avoidance and rejection of wider pathogenic stimuli, broader 
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threats to our biological fitness (e.g., unfavourable mates), and sociomoral transgressions that 
desecrate culturally-defined virtues of purity and divinity (e.g., sexual violations; Chapman & 
Anderson, 2012).  The most influential psychological model of disgust to date was proposed 
by Rozin and Fallon (1987) and distinguishes four categories of disgust elicitors: 1) a “core” 
set that includes animals, food, and body waste products (e.g., faeces, vomit, urine); 2) an 
“animal-nature” domain that reminds of us of our base status as animals (e.g., poor hygiene, 
death, violations of an idealised body envelope); 3) “interpersonal” (or contamination) 
disgust for contact with other persons; and 4) “moral” disgust elicited by sociomoral 
violations (Rozin, Haidt, & McCauley, 2008).  These theoretical divisions have been 
supported empirically, by factor analyses differentiating between core, animal-nature, and 
contamination-based disgusts (e.g., Olatunji, Williams, Lohr, Sawchuk, 2005; Olatunji et al., 
2007), and via unique predictive associations with other related constructs, including mental 
health outcomes (e.g., Olatunji et al., 2007).   
 Given its evolutionary grounding as a cornerstone of our “behavioural immune 
system” (Schaller & Park, 2011), disgust responding has a particular relevance in 
understanding people’s psychological reactions to disease and its treatment, not least 
significant threats to health, such as cancer (e.g., Reynolds, Consedine, Pizarro, & Bissett, 
2013).  Of the disgust categories outlined above, “core” (e.g., sickness, incontinence) and 
“animal-nature” (e.g., hair loss, scarring) disgust-eliciting side-effects are particularly 
relevant to cancer treatments.  An important mediational pathway through which the disgust-
related side-effects of cancer treatments may lead to increased depression and/or anxiety is 
via affect-congruent negative appraisals of the self.  In particular, cancer patients may come 
to appraise themselves (or certain self-aspects) as disgusting, which may then lead to 
heightened symptoms of depression and/or anxiety (e.g., Beck, 1967; Powell, Overton, 
Simpson, 2013).  Self-disgust has been shown to be a significant temporal antecedent of (i.e., 
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a consistent vulnerability factor for) depressive symptoms (Overton, Markland, Taggart, 
Bagshaw, & Simpson, 2008; Powell et al., 2013), and has also been linked to anxious 
responding (Olatunji, Cox, & Kim, 2015).  Furthermore, self-directed disgust has a 
hypothesised role in chronic physical health conditions, including cancer (Reynolds, 
McCambridge, & Consedine, 2015).  Broadly, people can experience enduring self-disgust 
toward their physical bodies and/or their behavioural acts (Overton et al., 2008), with 
independent predictive effects on measures of psychopathology (e.g., Powell et al., 2013).   
 In addition, one may expect the psychological impact of these disgust-related physical 
side-effects to be influenced by an individual’s underlying proneness to disgust (i.e., “disgust 
propensity”; van Overveld, de Jong, Peters, Cavanagh, & Davey, 2006), which is a trait 
individual difference factor that can be measured reliably by self-report (Olatunji, Cisler, 
Deacon, Connolly, & Lohr, 2007).  A recent prospective study by Reynolds, Bissett, and 
Consedine (2015) in patients with anal incontinence, for example, found that proneness to 
disgust negatively predicted a number of quality of life indices assessed 3 months later.  
Thus, one’s propensity to be disgusted can be hypothesised to be a critical moderator of the 
effects of disgust-related side-effects on self-directed disgust, and thus psychological health 
outcomes.  In particular, we would expect the effects of disgust-related side-effects on self-
disgust, and thus the mediational pathway described above, to be greater for those who were 
higher in disgust propensity.  
 In the present paper we tested the above mediation and moderation hypotheses in a 
community sample who reported having received treatment(s) for cancer.  In particular, we 
sought to explore: i) whether experiencing two types of disgust-related physical side-effects 
(i.e., “core” and “animal-nature”) were positively related to symptoms of depression and 
anxiety; ii) the degree that physical and/or behavioural self-disgust mediated the link between 
the presence of a disgust-related side-effect and depressive/anxious symptoms; and iii) 
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whether participants’ underlying propensity to disgust significantly moderated the impact of 
experiencing a disgust-related side-effect on self-directed disgust, and thus any indirect effect 
on depression and anxiety.  We predicted that: 
1)  Experiencing a disgust-related physical side-effect (“core” or “animal-nature”) would be 
positively related to symptoms of depression and anxiety. 
2)  Physical and/or behavioural self-disgust would positively mediate the effect of having a 
disgust-related side-effect on depression and anxiety.  
3) Trait propensity to disgust would positively moderate the effect of having a disgust-related 
physical side-effect on self-directed disgust. 
Method
Participants 
One hundred and thirty two community volunteers (83 women, Mage = 57.48 years, 
SDage = 14.19 years) who had been treated for a broad range of cancers participated in this 
study.  They were recruited from cancer charities and support groups.  Table 1 illustrates 
study participants’ characteristics.  No reimbursement was provided for participation. 
Measures 
 Cancer treatment and side-effects. 
All participants reported having being treated for cancer. Participants were asked 
whether they had received a particular treatment (e.g., chemotherapy; coded as 0 = had not 
received, 1 = had received; see Table 1).  They were also asked if their treatment(s) caused 
any side-effects, and if so to list them as a free-text response.  These free-text responses were 
coded for i) the number of side-effects reported (continuous scale); and ii) whether the 
participant reported a “core” or “animal-nature” disgust side-effect (0 = no, 1 = yes).  The 
decision to code a side-effect as related to “core” or “animal-nature” disgust was based on the 
conceptualisation provided by Rozin et al. (2008), and supported empirically by others (e.g., 
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Olatunji et al., 2007), that core disgust elicitors are related to food/eating and body waste 
products, and animal-nature disgust elicitors are related to death, hygiene, and body envelope 
violations.  Thus, a participant was coded as having experienced a “core” disgust-related 
side-effect if they reported any bowel and/or bladder problems or sickness and/or nausea.  An 
“animal-nature” side-effect was noted if participants reported a change to their physical body 
envelope (i.e., exterior form), including visible infections.  Examples of side-effects that were 
not coded as disgust-related included fatigue, pain, and motor problems.   
 Participants’ free-text responses were coded independently by two raters, the primary 
study author and an independent graduate student who was paid for their time.  The graduate 
student was unaffiliated with the current study and blind to its aims, and was directed to code 
the data using only the definitions given above.  Interrater agreement was high, with a two-
way absolute average-measures intraclass correlation coefficient (ICC; see Hallgren, 2012) of 
1.00, 95% CI [1.00, 1.00], p < .001 (97% agreement), for the number of side-effects; Siegel 
and Castellan’s (1988) kappa (κ) of .98, p < .001 (99% agreement) for “core” disgust side-
effects; and κ = 1.00, p < .001 (100% agreement) for “animal-nature” side-effects.  In the 
case of discrepancies, the independent secondary coding of the data was used for analyses. 
Disgust propensity and sensitivity.   
Participants’ disgust propensity (how easily one is disgusted) and disgust sensitivity 
(how negatively these disgust experiences are appraised) were measured using the Disgust 
Propensity and Sensitivity Scale-Revised (DPSS-R; van Overveld et al., 2006).  Participants 
rated their agreement to 16 items on a 5-point Likert scale (1 = never, 5 = always).  An 
example disgust propensity item is “I experience disgust”, and an example disgust sensitivity 
item is “It scares me when I feel nauseous”.  Disgust sensitivity was included as a control 
variable in the current analyses.  Based on psychometric evaluation of the DPSS-R (Goetz, 
Cougle, & Lee, 2013; Olatunji et al., 2007), a recommended 10-item solution (six items for 
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propensity and four for sensitivity) was used for analyses.  Both the disgust propensity, α 
= .78, and disgust sensitivity, α = .83, subscales demonstrated good internal reliability.  
Self-disgust. 
The Self-Disgust Scale (SDS; Overton et al., 2008) was used to measure participants’ 
trait disgust for the self.  For each of 18 items, participants rated their agreement on a 7-point 
Likert scale (1 = strongly agree, 7 = strongly disagree).  The scale contains a number of filler 
items and two 5-item subscales, one measuring physical self-disgust (e.g., “I find myself 
repulsive”) and the other behavioural self-disgust (“I often do things I find revolting”).  The 
internal reliabilities of the two subscales in the current sample were excellent, with α = .90 
and α = .83, respectively. 
Depression and anxiety. 
 Participants’ levels of anxiety and depression were measured using the Hospital 
Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983).  The scale was developed 
for use amongst hospital inpatients and has been previously validated in community patients 
with cancer (e.g., Smith et al., 2002).  For 14 items (seven for each subscale) participants 
rated their current agreement on a 4-point scale (0-3, with reversed labels).  An example item 
from the anxiety subscale is “I get sudden feelings of panic”, and an example from the 
depression subscale is “I feel as if I am slowed down”.  In the current sample, the Cronbach’s 
alpha coefficients for the anxiety, α = .88, and depression, α = .84, subscales were good.   
 To maintain consistency with prior research on disgust in the context of depression 
(e.g., Overton et al., 2008; Powell et al., 2013), and to account for potential criticisms of the 
sensitivity of the HADS depression subscale (see Luckett et al., 2010), a second measure of 
depression was included in the surveys, the 7-item depression subscale of the short-form 
Depression, Anxiety, and Stress Scales (DASS–21; Lovibond & Lovibond, 1995).  For each 
item (e.g., “I felt that life was meaningless”) participants indicated how much it had applied 
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to them over the previous week on a 4-point Likert scale (0 = did not apply to me at all, 3 = 
applied to me very much, or most of the time).  Summative scores were multiplied by two to 
make them comparable with the extended form of the DASS (Lovibond & Lovibond, 1995).  
The internal consistency of this scale was excellent, α = .94. 
Control variables. 
 In our path analyses we controlled for observed variables that we expected, a priori, to 
have a significant relationship with symptoms of depression and anxiety, including gender, 
age, years since cancer diagnosis, number of side-effects reported, disgust sensitivity, and 
whether the participant reported a current medical diagnosis of depression (0 = no, 1 = yes) or 
anxiety (0 = no, 1 = yes).  Bivariate correlations showed that all control variables were 
significantly related to at least two of the three outcome variables (rs = .18 - .46).  Analyses 
without the inclusion of control variables produced the same (stronger) pattern of results.  
Procedure 
Ethical approval was granted by the host research institution prior to data collection.  
All procedures were in accordance with the ethical standards of the institutional research 
committee and with the 1964 Helsinki declaration and its later amendments.  Informed 
consent was obtained from all individual participants included in the study.  As part of a 
larger survey into psychological responses to cancer, cancer charities and support groups 
were approached with a link to an online survey.  Volunteers completed the measures listed 
above online in a counterbalanced order and were fully debriefed.    
Data Analysis 
Missing data were minimal, with a single missing value on the depression subscale of 
the DASS (Lovibond & Lovibond, 1995).  To minimise data loss, we imputed this value at 
the mean of available data.  Following descriptive and correlational analyses on SPSS v. 21 
(IBM Corp., Armonk, NY, US), path analysis on AMOS v. 22 (IBM Corp., Armonk, NY, 
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US) was used to model the hypothesised relationships between the variables.  Path analysis 
has several advantages over standard multiple regression, including the estimation of direct 
and indirect effects (through mediating variables) simultaneously; the ability to model 
multiple endogenous (i.e., dependent) variables at the same time, allowing one to account for 
their interdependence caused by extraneous variables (by correlating their error terms); and 
the calculation of multiple measures of fit to the data.  Further, it is a less resource-intensive 
technique than structural equation modelling (SEM), which typically requires a larger 
sample, due to the inclusion of latent variables (Wolf, Harrington, Clark, & Miller, 2013).    
As recommended by Hayes (e.g., Hayes, 2009; Hayes & Scharkow, 2013), bias-
corrected percentile bootstrapping was used to produce robust confidence intervals and 
standard errors (and hence probability values) for all estimates, including direct and indirect 
effects, removing any restrictions on the underlying sampling distribution.  Bootstrapping 
provides a non-parametric robust alternative to traditional parametric estimates, when those 
estimates may be biased due, for example, to the violation of parametric assumptions and/or a 
restricted sample size (Fox, 2008).  Ten thousand resamples were used for the bootstrapped 
estimates (Mallinckrodt, Abraham, Wei, & Russell, 2006).   The Bollen and Stine (1992) 
bootstrap adjusted p-value was interpreted to assess model fit based on the chi-square 
statistic, along with the CFI and RMSEA.  After fitting the model, to obtain separate 
bootstrapped estimates of specific indirect effects through a single mediator (not provided by 
default in AMOS), the path from the predictor to the alternative mediator was constrained to 
zero, as was the correlation between the two mediators (MacKinnon, 2008).  To reduce 
potential multicollinearity associated with the inclusion of an interaction term, all continuous 
predictors (and mediators) were centred prior to analysis. 
Results 
Descriptives and Correlations 
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Initial bivariate correlations and descriptive data for the primary study variables are 
presented in Table 2.  One hundred and nineteen participants (90%) reported at least one side-
effect from their treatment(s).  The average number of side-effects reported per participant 
was 3.36 (SD = 2.60).  Forty-five (34.1%) participants reported a “core” disgust side-effect, 
and 55 (41.7%) an “animal-nature” disgust side-effect, from their treatment(s).  The results 
from the HADS are broadly similar to those reported for other heterogeneous cancer samples 
(e.g., Smith et al., 2002), with higher scores for anxiety than depression.  In a large varied 
cancer sample, Smith et al. (2002) reported a mean of 4.38 for depression and 6.05 for 
anxiety, with 33.3% of participants presenting with clinically-relevant symptoms of anxiety 
and 19.8% with clinically-relevant symptoms of depression (Zigmond & Snaith, 1983).  
Using the same criteria (scores ≥ 8 indicating potentially clinically-relevant symptoms; 
Zigmond & Snaith, 1983), 19.7% of our sample presented with current indicative symptoms 
of depression, but approximately 50.0% presented with indicative symptoms of anxiety.  The 
DASS has been used less in cancer samples (Luckett et al., 2010), but indicated a potentially 
higher level of depressive symptoms in the participants over the previous week.  Using the 
criteria of Lovibond and Lovibond (1995), 37.9% presented with mild-to-severe symptoms of 
depression using the DASS (scores ≥ 10), suggesting it may be a more sensitive measure of, 
at least, mild depressive states (Luckett et al., 2010). 
 Partial support was found for prediction (1); total number of side-effects reported was 
significantly bivariately-related to symptoms of depression (HADS), r = .19, p < .05, and 
depression (DASS), r = .18, p < .05, but not anxiety, r = .14, p = .111.  Reporting a core 
disgust side-effect was significantly positively related to symptoms of depression (HADS), 
rpb = .23, p < .01, and depression (DASS), rpb = .27, p < .01, and had a borderline significant 
relationship with anxiety, rpb = .16, p < .10.  However, reporting an animal-nature side-effect 
was not related to depression (HADS), rpb = −.03, p = .716, depression (DASS), rpb = −.11, p
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= .219, or anxiety, rpb = −.06, p = .532, nor was it significantly related to any of the measured 
disgust traits.  Accordingly, only the core disgust-related side-effect variable was included in 
the path analyses below.  Experiencing a core disgust side-effect was significantly positively 
related to physical, rpb = .20, p < .05, and behavioural, rpb = .22, p < .05, self-disgust, and 
borderline significantly related to disgust sensitivity, rpb = .16, p < .10.  All the proposed 
mediating and outcome variables were significantly related (p < .001).   
Path Models 
 Model 1 (mediation). 
 We estimated two path models to test predictions (2) and (3).  The first was a 
mediation model, with core disgust side-effects and disgust propensity as the exogenous 
predictors, physical and behavioural self-disgust as hypothesised mediators, and depression 
(HADS), depression (DASS), and anxiety as outcomes (Figure 1).  In this model, regression 
weights on the disgust propensity*core side-effect interaction term were constrained to zero.  
The model fit the data reasonably well, χ2(5) = 9.45, p = .174; CFI = 0.99; RMSEA = 0.08, 
90% CI [0.00, 0.16], p = .210.  All path estimates and associated maximum likelihood and 
bootstrap SEs/CIs are presented in Table 3.  Reporting a core disgust side-effect significantly 
predicted behavioural, β= .17, p < .05, but not physical, β= .14, p = .119, self-disgust.  
Physical self-disgust significantly predicted depression (HADS), β= .57, p < .001, 
depression (DASS), β= .42, p < .01, and anxiety, β= .27, p < .05.  Similarly, behavioural 
self-disgust significantly predicted depression (DASS), β= .27, p < .05, and anxiety, 
β= .23, p < .05, but not current depression as measured by the HADS, β= .06, p = .566.                    
 The direct effects of experiencing a core disgust side-effect on depression (HADS), 
β= .07, p = .287, depression (DASS), β= .11, p = .129, and anxiety, β= −.01, p = .997, 
were not significant.  The indirect effect of core disgust side-effects through physical self-
disgust was borderline significant for depression (DASS), β= .06, p < .10, and anxiety, 
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β= .04, p < .10, but not significant for depression (HADS), β= .08, p = .105, while 
the indirect effect of core disgust side-effects via behavioural self-disgust was statistically 
significant for depression (DASS), β= .05, p < .05, and anxiety, β= .04, p < .05, but 
not depression (HADS), β= .01, p = .383.  The total indirect effect of core disgust side-
effects through self-disgust was borderline significant for depression (HADS), β,,= .09, 
p < .10, depression (DASS), β,,= .11, p < .10, and anxiety, β,,= .08, p < .10.   
Model 2 (moderated mediation).       
 Second, we estimated a moderated mediation model, by removing the parameter 
constraints on the disgust propensity*core disgust-related side-effect interaction term (Figure 
2).  This model fit the data very well, χ2(3) = 2.82, p = .530, CFI = 1.00, RMSEA = 0.00, 
90% CI [0.00, 0.14], p = .555, showing a significant improvement in overall model fit over 
the constrained model, Δχ2(2) = 6.63, p < .05.  The interaction term significantly positively 
predicted behavioural self-disgust, β= .25, p < .05, and borderline-significantly predicted 
physical self-disgust, β= .18, p < .10.  To clarify the nature of the moderating effect, the 
effects of experiencing a core disgust-related side effect on (physical and behavioural) self-
disgust were estimated at three levels of disgust propensity (− 1 SD, M, + 1 SD).  As shown 
in Figure 3, having a core disgust side-effect significantly predicted behavioural self-disgust 
at high, β= .36, p < .05, but not low or moderate levels of disgust propensity.  This pattern 
was the same for physical self-disgust.  Tests of mediation (model 1) at differing levels of 
disgust propensity reflected the above; self-disgust significantly mediated the relationship 
between core disgust side-effects and depression and anxiety only when disgust propensity 
was high, providing evidence of moderated mediation (see Table 4).   
Discussion 
 In this paper we explored the relationship between disgust-related physical side-
effects of cancer treatments and individuals’ symptoms of depression and anxiety.  Our first 
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prediction (1), that disgust-related side-effects would be positively related to mental health 
symptoms, received partial support.  Reporting a “core” (e.g., incontinence), but not “animal-
nature” (e.g., hair loss) disgust side-effect (vs. having no or any other type of side-effect) was 
positively related to symptoms of depression and anxiety.  There are at least three reasons 
why disgust-related side-effects may be especially associated with states of depression and/or 
anxiety.  First, disgust has been implicated in the phenomenology of depressed mood, which 
is theorised to be a combination of sadness and self-disgust (Alanazi et al., 2015; Power & 
Dalgleish, 2008).  Second, disgust is socioculturally-determined (Rozin et al., 2008), and in 
experiencing disgust there is an implicit appraisal that the same stimulus would be disgusting 
to others.  Individuals experiencing self-disgust think that they are repulsive to other people 
(Powell, Overton, & Simpson, 2014).  Disgust causes a negative interpretation bias (Davey, 
Bickerstaffe, & MacDonald, 2006), motivates avoidance (Rozin & Fallon, 1987), and is 
associated with stigma (Park, Schaller, & Crandall, 2007).  Vartanian (2010), for example, 
found disgust to be a stronger predictor of obesity stigma in undergraduate students than 
attributions of control or demographic factors (e.g., body mass index).  Thus, disgust-related 
side-effects may increase the perceived (and actual) prejudicial discrimination patients 
receive from others, and/or increase social isolation (Powell et al., 2014), leading to 
heightened anxiety and/or depression (e.g., Else-Quest, LoConte, Schiller, & Hyde, 2009).  
Third, disgust is linked to other negative self-conscious emotional states (e.g., shame; Alanazi 
et al., 2015; Powell et al., 2014), and dysfunctional thought processes (Overton et al., 2008), 
which are linked to depression and anxiety (e.g., Gilbert, 2000).       
 It is unclear, however, why the animal-nature disgust side-effects did not show the 
same pattern of results as core disgust side-effects in this sample.  It may be that there is a 
greater range of side-effects in this grouping (e.g., “ulceration” to “facial reconstruction”), 
than in core disgust side-effects, which constitute a more narrowly-defined class of elicitors 
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(i.e., bodily waste products), thus obscuring any effects at the aggregate level.  Further work 
with larger samples may be able to explore this heterogeneity in greater detail.  Further, it 
may be that the animal-nature category suffered from a lack of validity (i.e., our sample of 
cancer patients did not actually find these side-effects disgusting).  Certain animal-nature 
side-effects (e.g., hair loss) may be more accepted socially, particularly in the context of 
cancer, than core disgust side-effects (e.g., incontinence; Reeve, 2015).  Furthermore, disgust 
is heterogeneous (Simpson, Carter, Anthony, & Overton, 2006); core disgust stimuli (e.g., 
faeces) are considered some of the most salient and universal disgust-provoking objects in 
existence (Rozin et al., 2008).  They elicit disgust in almost all adults, while animal-nature 
disgust shows greater variability (Haidt, 2015).  This factor too may contribute to the stronger 
impact of core (vs. animal-nature) disgust side-effects on mental health.  
 In general, predictions (2) and (3) were supported through a moderated mediation 
model (Figure 2).  Regarding (2), the impact of core disgust side-effects on depression and 
anxiety were fully explained by indirect effects through self-directed disgust, significantly 
predicting two out of three outcome variables (DASS depression and HADS anxiety).  The 
specific indirect effects were larger through behavioural than physical self-disgust, 
presumably representing the nature of the core disgust category as measured in this study 
(i.e., problems with bodily waste products, including incontinence and sickness, typically 
constitute disgusting behaviours rather than necessitate alterations to the physical self).  That 
a significant mediation effect was observed for only one of the depression indices (DASS) 
included in the study, and not the HADS depression subscale (although this effect was 
borderline), raises questions about measurement.  First, the HADS asked about current (i.e., 
“in-the-moment”) symptoms of depression, while the DASS measures symptoms over the 
previous week, which may help to explain this discrepancy.  Second, the HADS has been 
criticised as having a reduced sensitivity to minor depression (Luckett et al., 2010).  Thus, the 
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DASS may be a more sensitive instrument than the HADS, yet its use in cancer samples 
remains limited.  Of course, the way self-report measures such as this may translate to 
clinical outcomes should be interpreted with caution.      
Supporting prediction (3), disgust proneness positively moderated the effect of 
experiencing core disgust side-effects on self-disgust.  This is consistent with prior work in 
the field, showing a potentially detrimental interactive effect between individuals’ disgust 
proneness and exposure to one’s core bodily disgust elicitors on psychological well-being 
(Reynolds, Bissett et al., 2015; Smith et al., 2007).  This significant interaction also supports 
the contention that it is the disgust(ing) aspect of these physical side-effects that contributes 
to the development of trait self-disgust, and thereby symptoms of depression and anxiety.    
As well as depression (Overton et al., 2008) and anxiety (Olatunji et al., 2015), self-
disgust has been shown to be involved in a number of, often comorbid, mental health issues, 
including eating (Moncrieff-Boyd, Allen, Byrne, & Nunn, 2014) and personality (Abdul-
Hamid, Denman, & Dudas, 2014) disorders.  A model of enduring, problematic self-disgust 
as an “emotion schema” was outlined by Powell, Simpson, and Overton (2015a).  Powell et 
al. (2015a) described self-disgust as a lasting disgust-based cognitive-affective orientation 
toward (an aspect of) the self, composed of interacting state and higher-order trait 
components, the latter of which are largely cognitive and persist over time (i.e., “my body is 
revolting”).  Importantly, self-disgust has been shown to be relatively temporally stable 
(Powell et al., 2013), and thus is likely to be particularly detrimental based on its schematic, 
top-down influence on information processing (Powell et al., 2015a).  Self-disgust is formed 
either during the acquisition of disgust, as one learns that certain self-aspects fit within an 
emerging repertoire of disgust elicitors, or through a dramatic change in the self (e.g., via 
physical trauma) that is then appraised as disgusting (Powell et al., 2015a).  The latter would 
explain self-disgust as a consequence of disgust-related side-effects of cancer treatment. 
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 The findings from this study have implications for understanding patients’ 
psychological adaptation to cancer treatments, and they add to a literature on the importance 
of addressing emotional factors in the aetiology of mental health problems (Greenberg, 
2008).  This work suggests that the core disgust side-effects possible in cancer treatments 
may be particularly deleterious to psychological wellbeing through increases in (behavioural) 
self-directed disgust.  There are two potential points for intervention.  First, it is possible to 
identify, by measuring disgust proneness, which patients may particularly suffer as a result of 
these side-effects, and to monitor and treat them accordingly (Reynolds, Bissett et al., 2015).  
There is evidence that cognitive reappraisal (vs. e.g., affective suppression) may be a useful 
strategy for the psychological regulation of disgust, and that it can be primed in the laboratory 
(e.g., Goldin, McRae, Ramel, & Gross, 2008; Gross, 1998).  Second, reducing the enduring 
self-disgust associated with core disgust side-effects may disrupt the link with depressive and 
anxious outcomes.  Recent experimental work has shown that the self-affirmation of valued 
character traits may be a promising tool for reducing in-the-moment feelings of self-directed 
disgust (Powell, Simpson, & Overton, 2015b).  Paul Gilbert’s “compassion-focused therapy” 
is another approach formulated to work with people with high levels of self-criticism, hatred, 
and disgust (Gilbert, 2015).  Nevertheless, research on the effective regulation and treatment 
of disgust is in its infancy and there are plentiful opportunities for future work in this area; 
what is critical, in this context, is that the emotional (i.e., disgust) component forms the 
primary target for clinical intervention (Whelton & Greenberg, 2005). 
 This study is limited by its cross-sectional design.  While mediation normally requires 
a temporal lag between observed variables, a strong theoretical justification can be made for 
the proposed directionality of the current model.  In particular, treatment side-effects can be 
viewed as primarily exogenous to self-disgust (i.e., they are more likely to cause self-disgust 
than the reverse; a pathway that is moderated by disgust proneness).  In turn, previous 
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longitudinal work has shown that self-disgust (as measured by the SDS; Overton et al., 2008) 
significantly predicts depressive symptoms (as measured by the DASS; Lovibond & 
Lovibond, 1995) – and not the reverse – over 6- and 12-month periods (Powell et al., 2013).  
Given the strong relationship observed between symptoms of depression (DASS) and 
anxiety, r = .62, p < .001, we assume this directional pattern to be analogous for anxiety.  
Nevertheless, reverse effects to those hypothesised are possible; the side-effects measure is 
subjective and limited by recollection, so it is plausible that people who had higher levels of 
self-disgust at data collection were more likely to recall disgust-related side-effects.  Further, 
disgust propensity may be affected by self-disgust (and mental health) as much as the reverse.  
Experimental designs (i.e., focusing on reducing disgust) are necessary to establish causation 
and test between the above alternative explanations.  
 This study is also limited by its modest sample size.  However, this sample exhibited 
very similar levels of depressive symptoms (HADS) to a larger heterogeneous cancer sample 
(e.g., Smith et al., 2002), suggesting a degree of representativeness.  While all cell sizes for 
the dummy side-effect variables were above a commonly-accepted minimum (30 cases), the 
reduction in cell sizes that would occur by further subsampling by side-effect type restricts 
the utility of such an analysis (Gordon, 2010).  The study is also limited by our aggregated, 
“top-level” analysis of physical side-effects.  While we control for some important factors 
(e.g., years since cancer diagnosis), we do not have available deeper information on 
participants’ side-effects, such as their temporal permanency or recency, which may be key 
moderators of the effects observed.  Nevertheless, the fact that an effect is obtained at the 
“top-level” of these events (i.e., experiencing a core disgust side-effect or not) is impressive 
and speaks to the enduring power of acquired disgust, which is particularly resistant to 
temporal extinction (Olatunji, Forsyth, & Cherian, 2007).  Future work may explore how the 
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above (and other) conditioning variables influence the impact of core disgust side-effects and 
how patients’ disgust appraisals change as a result.    
 This study was the first to explore quantitatively the effects of disgust-related physical 
side-effects of cancer treatment on mental health outcomes.  The findings suggest that disgust 
matters; people who had experienced a core disgust side-effect (vs. no or any other kind of 
side-effect) exhibited higher levels of depression and anxiety.  Furthermore, this association 
was explained entirely by increased self-directed disgust, as moderated by trait disgust 
proneness.  Taken together, these findings stress the importance of emotional factors (i.e., 
disgust) in psychological adaptation to the side-effects of cancer treatment.  They suggest that 
disgust-targeted interventions may be useful in reducing self-disgust and/or disgust proneness 
in individuals exposed to relevant side-effects in order to improve mental health outcomes.       
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Figure Captions 
Figure 1. Mediation model explaining the effect of “core” disgust side-effects on symptoms of depression and anxiety in people treated for cancer.  Self-disgust significantly 
mediated the effect of experiencing a core disgust side-effect on symptoms of mental health, with significant indirect effects through behavioural self-disgust on depression 
(DASS), β= .05, p < .05, and anxiety, β= .04, p < .05; and borderline-significant indirect effects through physical self-disgust on depression (DASS), β= .06, p
< .10, and anxiety, β= .04, p < .10.  Regression coefficients associated with the interaction term (a5-6) were constrained to zero.  Control variables and error terms are 
omitted for clarity.  Estimates on the endogenous variables were conditioned on: gender, age, years since diagnosis, number of side-effects reported, disgust sensitivity, and 
medical diagnoses of depression or anxiety.  Error terms for the pair of mediators (physical and behavioural self-disgust) were correlated, as were the error terms for the three 
outcome variables (depression and anxiety).  All estimates are standardised betas (β).  Significance levels were determined based on bootstrapped CIs (10000 resamples).  A 
chi-square test with Bollen-Stine bootstrap indicated adequate model fit, χ2(5) = 9.45, p = .174; CFI = 0.99; RMSEA = 0.08, p = .210.  *p < .05. **p < .01. ***p < .001.     
Figure 2. Moderated mediation model explaining the effect of “core” disgust side-effects on symptoms of depression and anxiety in people treated for cancer.  Propensity to 
disgust significantly positively moderated the effect of experiencing a core disgust side-effect on behavioural self-disgust, β= .25, p < .05, and had a borderline-significant 
moderation effect on physical self-disgust, β= .18, p < .10.  Control variables and error terms are omitted for clarity.  Estimates on the endogenous variables were 
conditioned on: gender, age, years since diagnosis, number of side-effects reported, disgust sensitivity, and medical diagnoses of depression or anxiety.  Error terms for the 
pair of mediators (physical and behavioural self-disgust) were correlated, as were the error terms for the three outcome variables (depression and anxiety).  All estimates are 
standardised betas (β).  Significance levels were determined based on bootstrapped CIs (10000 resamples).  A chi-square test with Bollen-Stine bootstrap indicated excellent 
model fit, χ2(3) = 2.82, p = .530, CFI = 1.00, RMSEA = 0.00, 90% CI [0.00, 0.14], p = .555.  †p < .10. *p < .05. **p < .01. ***p < .001. 
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Figure 3. Simple slopes analysis explaining the effect of experiencing a “core” disgust-related side-effect on levels of behavioural self-disgust at three levels of underlying 
disgust propensity (− 1 SD = “low”; M = “mean”; & + 1 SD = “high”).  Experiencing a core disgust side-effect significantly predicted greater behavioural self-disgust only 
when disgust propensity was high.  This pattern of results is the same for physical self-disgust (not shown).     




Gender 49 men (37.1%); 83 women (62.9%) 
Age Range = 19-85; M = 57.48; SD = 14.19 
Years since diagnosis  Range = 0-21; M = 5.42; SD = 4.87 
Primary cancer diagnosisa 1 blood (0.7%); 3 bone (2.1%); 10 brain (7.1%); 38 breast (27.1%); 6 colorectal 
(4.3%); 24 gynaecological (17.1%); 29 head and neck (20.7%); 4 lung (2.9%); 17 
prostate (12.1%); 4 skin (2.9%); 1 stomach (0.7%); 1 testicular (0.7%); 2 
unspecified (1.4%) 
Treatmenta 6 biological therapy (4.5%); 59 chemotherapy (44.7%); 41 hormonal therapy 
(31.1%); 78 radiotherapy (59.1%); 1 stem cell/bone marrow transplant (0.8%); 107 
surgery (81.1%) 
Diagnosed as depressed 12 yes (9.1%); 120 no (90.9%) 
Diagnosed as anxious 14 yes (10.6%); 118 no (89.4%) 
Note. N = 132.  aAbsolute values greater than N because five participants reported more than one type of 
primary cancer and the majority of participants had received multiple treatments for their cancer.
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Table 2 
Means (M), standard deviations (SD), range, and inter-correlations of study variables 
 1 2 3 4 5 6 7 8 9 10 
1.  Number of side-effects —
2.  Core disgust side-effect .42*** —
3. Animal nature side-effect  .53*** .14 —
4.  Physical self-disgust .20* .20* .05 —
5. Behavioural self-disgust .16† .22* .02 .78*** —
6.  Disgust propensity .10 .10 .07 .28** .24** —
7.  Disgust sensitivity .23** .16† .14 .38*** .36*** .65*** —
8.  Anxiety .14 .16† −.06 .60*** .58*** .30*** .46*** —
9.  Depression (HADS) .19* .23** −.03 .72*** .60*** .27** .40*** .66*** —
10. Depression (DASS) .18* .27** −.11 .70*** .66*** .29** .40*** .62*** .77*** —
Range 0-12 0-1 0-1 5-35 5-31 6-30 4-20 0-19 0-21 0-42 
M 3.36 0.34 0.42 13.04 11.12 14.33 8.51 7.52 4.88 8.93 
SD 2.60 0.48 0.49 7.66 6.08 3.88 3.65 4.71 4.03 10.34 
Note. N = 132.  Correlations represent Pearson’s r, pointbiseral (rpb), or phi (rϕ) coefficients.  HADS = Hospital 
Anxiety and Depression Scale; DASS = Depression Anxiety and Stress Scales.  †p < .10. *p < .05. **p < .01. 
***p < .001. 
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Table 3 
Path estimates for the mediation model (Figure 1) 
Path Estimates  SE of b  Bootstrap 95% CIs b  Bootstrap 95% CIs β
b β  ML Bootstrap  Lower Upper  Lower Upper 
Direct path estimates 
a1 2.27 .14  1.34 1.49  −0.57 5.28  −.04 .33 
a2 2.19* .17  1.11 1.15  0.03 4.52  .00 .35 
a3 0.06 .03  0.20 0.22  −0.37 0.47  −.19 .23 
a4 0.01 .01  0.17 0.19  −0.36 0.38  −.24 .23 
b1 0.30*** .57  0.05 0.06  0.20 0.41  .37 .76 
b2 0.56** .42  0.14 0.18  0.18 0.90  .14 .67 
b3 0.17* .27  0.07 0.07  0.03 0.29  .05 .47 
b4 0.04 .06  0.06 0.07  −0.10 0.17  −.15 .26 
b5 0.47* .27  0.16 0.22  0.04 0.88  .02 .52 
b6 0.18* .23  0.08 0.08  0.03 0.33  .04 .43 
c1 0.56 .07  0.53 0.57  −0.51 1.73  −.06 .20 
c2 2.29 .11  1.42 1.61  −0.70 5.67  −.03 .25 
c3 −0.05 −.01  0.69 0.72  −1.40 1.41  −.14 .15 
c4 −0.10 −.09  0.08 0.08  −0.27 0.06  −.26 .06 
c5 −0.07 −.03  0.21 0.20  −0.48 0.32  −.17 .13 
c6 −0.03 −.03  0.10 0.10  −0.24 0.15  −.19 .13 
Indirect path estimates (mediation) 
a1b1 0.68 .08  --- 0.49  −0.14 1.80  −.02 .21 
a1b2 1.27† .06  --- 0.98  −0.12 3.94  −.01 .19 
a1b3 0.38† .04  --- 0.31  −0.04 1.25  −.00 .13 
a2b4 0.08 .01  --- 0.17  −0.17 0.59  −.02 .07 
a2b5 1.02* .05  --- 0.79  0.03 3.35  .00 .16 
a2b6 0.39* .04  --- 0.27  0.03 1.20  .00 .12 
a3b1 0.02 .02  --- 0.07  −0.11 0.15  −.11 .14 
a3b2 0.03 .01  --- 0.13  −0.22 0.30  −.09 .12 
a3b3 0.01 .01  --- 0.04  −0.06 0.10  −.05 .08 
a4b4 0.00 .00  --- 0.01  −0.03 0.04  −.03 .03 
a4b5 0.00 .00  --- 0.10  −0.21 0.21  −.09 .08 
a4b6 0.00 .00  --- 0.04  −0.07 0.08  −.06 .06 
a1,2b1,4 0.76† .09  --- 0.50  −0.13 1.84  −.02 .21 
a1,2b2,5 2.30† .11  --- 1.32  −0.16 .5.05  −.01 .22 
a1,2b3,6 0.77† .08  --- 0.44  −0.02 1.73  −.00 .17 
a1,2b1,4 0.02 .02  --- 0.07  −0.12 0.16  −.12 .15 
a1,2b2,5 0.04 .01  --- 0.20  −0.36 0.44  −.14 .16 
a1,2b3,6 0.01 .01  --- 0.07  −0.12 0.14  −.10 .11 
Note. N = 132.  ML = Maximum likelihood estimation.  Continuous predictor variables centred.  Probability 
values determined on bootstrapped CIs (10000 resamples).  †p < .10. *p < .05. **p < .01. ***p < .001. 
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Table 4 
Additional path estimates for the moderated mediation model (Figure 2)   
Path Estimates  SE of b  Bootstrap 95% CIs b  Bootstrap 95% CIs β
b β  ML Bootstrap  Lower Upper  Lower Upper 
Direct (moderation) path estimates 
a5 0.70† .18  0.36 0.40  −0.11 1.45  −.02 .38 
a6 0.76* .25  0.29 0.35  0.05 1.41  .02 .47 
Indirect path estimates (mediation) at three levels of disgust propensity 
Moderate disgust propensity (M) 
a1b1 0.53 .06  --- 0.47  −0.27 1.63  −.03 .18 
a1b2 1.00 .05  --- 0.93  −0.33 3.56  −.02 .17 
a1b3 0.30 .03  --- 0.29  −0.10 1.12  −.01 .12 
a2b4 0.06 .01  --- 0.14  −0.12 0.51  −.01 .06 
a2b5 0.77† .04  --- 0.69  −0.07 2.86  −.00 .14 
a2b6 0.29† .03  --- 0.24  −0.02 1.00  −.00 .10 
a1,2b1,4 0.59 .07  --- 0.48  −0.27 1.61  −.03 .19 
a1,2b2,5 1.77 .08  --- 1.25  −0.61 4.30  −.03 .19 
a1,2b3,6 0.59 .06  --- 0.42  −0.18 1.47  −.02 .15 
High disgust propensity (+ 1 SD) 
a1b1 1.34* .16  --- 0.69  0.14 2.91  .02 .33 
a1b2 2.51* .12  --- 1.50  0.34 6.53  .02 .31 
a1b3 0.75* .08  --- 0.47  0.08 2.04  .01 .21 
a2b4 0.17 .02  --- 0.34  −0.41 1.03  −.05 .13 
a2b5 2.15* .11  --- 1.38  0.25 6.00  .01 .29 
a2b6 0.82* .09  --- 0.49  0.13 2.19  .01 .23 
a1,2b1,4 1.51* .18  --- 0.73  0.22 3.15  .02 .35 
a1,2b2,5 4.66* .21  --- 2.03  0.96 8.94  .04 .40 
a1,2b3,6 1.57* .16  --- 0.68  0.35 3.07  .03 .31 
Low disgust propensity (− 1 SD) 
a1b1 −0.27 −.03  --- 0.65  −1.56 1.04  −.19 .13 
a1b2 −0.51 −.03  --- 1.27  −3.48 0.55  −.17 .08 
a1b3 −0.15 −.02  --- 0.39  −1.07 1.73  −.11 .06 
a2b4 −0.05 −.01  --- 0.15  −0.63 0.12  −.08 .01 
a2b5 −0.61 −.03  --- 0.88  −2.99 0.72  −.15 .04 
a2b6 −0.23 −.02  --- 0.33  −1.15 0.25  −.12 .03 
a1,2b1,4 −0.32 −.04  --- 0.70  −1.74 1.04  −.20 .12 
a1,2b2,5 −1.13 −.05  --- 1.88  −5.11 2.42  −.23 .11 
a1,2b3,6 −0.39 −.04  --- 0.62  −1.65 0.82  −.17 .08 
Note. N = 132.  ML = Maximum likelihood estimation.  Continuous predictor variables centred.  Probability 
values determined on bootstrapped CIs (10000 resamples).  †p < .10. *p < .05. **p < .01. ***p < .001. 
